Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort study

Affiliations

• ¹ Department of Thrombosis and Haemostasis, University College Hospital, London, United Kingdom of Great Britain and Northern Ireland; Department of Haematology, Whittington NHS Trust, London, United Kingdom of Great Britain and Northern Ireland. Electronic address: zara.sayar@nhs.net.
• ² Department of Thrombosis and Haemostasis, University College Hospital, London, United Kingdom of Great Britain and Northern Ireland.
• ³ Department of Haematology, University College Hospital, London, United Kingdom of Great Britain and Northern Ireland.
• ⁴ Cancer Division, University College Hospital, London, United Kingdom of Great Britain and Northern Ireland.
• ⁵ Department of Thrombosis and Haemostasis, University College Hospital, London, United Kingdom of Great Britain and Northern Ireland; Cardiometabolic Biomedical Research Centre, University College London, United Kingdom of Great Britain and Northern Ireland.